Barings Backs Soleus Capital with $3.5B Healthcare Financing Facility
Event summary
- Barings provided a senior secured financing facility to Soleus Capital to expand its healthcare credit and royalty platform.
- The facility is secured by a diversified portfolio of established royalties from commercial-stage pharmaceutical products.
- Soleus Capital manages approximately $3.5 billion in assets as of June 30, 2026.
- Barings has $502 billion in assets under management as of June 30, 2026.
The big picture
The transaction reflects the increasing need for flexible, non-dilutive financing solutions in the healthcare sector, particularly for companies looking to commercialize therapies and advance clinical development. Barings' involvement underscores the strategic importance of asset-based investment opportunities with contractual cash flows, which are less correlated to traditional corporate credit and equity markets. This deal highlights the growing intersection of private credit and life sciences innovation.
What we're watching
- Market Demand
- How growing demand for specialized financing solutions among emerging and middle-market life sciences companies will impact Soleus Capital's growth.
- Strategic Collaboration
- Whether the partnership between Barings and Soleus Capital will lead to future collaborations and facility upsizing.
- Portfolio Diversification
- The pace at which Barings can deploy additional capital through potential facility upsizing to support future Soleus transactions.
Related topics